BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jabbour SK, Mulvihill D. Defining the role of adjuvant therapy: ampullary and duodenal adenocarcinoma. Semin Radiat Oncol. 2014;24:85-93. [PMID: 24635865 DOI: 10.1016/j.semradonc.2013.11.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang W, Liu Q, Zhao ZM, Tan XL, Wang ZZ, Zhang KD, Liu R. Comparison of robotic and open pancreaticoduodenectomy for primary nonampullary duodenal adenocarcinoma: a retrospective cohort study. Langenbecks Arch Surg 2021. [PMID: 34471952 DOI: 10.1007/s00423-021-02303-9] [Reference Citation Analysis]
2 Dasari BV, Roberts KJ, Hodson J, Stevens L, Smith AM, Hubscher SG, Isaac J, Muiesan P, Sutcliffe RP, Marudanayagam R, Mirza DF. A model to predict survival following pancreaticoduodenectomy for malignancy based on tumour site, stage and lymph node ratio. HPB (Oxford) 2016;18:332-8. [PMID: 27037202 DOI: 10.1016/j.hpb.2015.11.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
3 Lim YJ, Kim K. Effect of postoperative radiotherapy on survival in duodenal adenocarcinoma: a propensity score-adjusted analysis of Surveillance, Epidemiology, and End Results database. Int J Clin Oncol 2018;23:473-81. [DOI: 10.1007/s10147-017-1226-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
4 Skowronek J, Zwierzchowski G. Brachytherapy in the treatment of bile duct cancer - a tough challenge. J Contemp Brachytherapy. 2017;9:187-195. [PMID: 28533809 DOI: 10.5114/jcb.2017.66893] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
5 Fujimoto T, Ohtsuka T, Date K, Kimura H, Matsunaga T, Mori Y, Miyasaka Y, Mochidome N, Oda Y, Nakamura M. Expression of Bcl-2 19-kDa interacting protein 3 predicts prognosis after ampullary carcinoma resection: Expression of Bcl-2 19-kDa interacting protein 3 predicts prognosis after ampullary carcinoma resection. J Hepatobiliary Pancreat Sci 2016;23:489-96. [DOI: 10.1002/jhbp.367] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Nappo G, Galvanin J, Gentile D, Capretti G, Pulvirenti A, Bozzarelli S, Rimassa L, Spaggiari P, Carrara S, Petitti T, Gavazzi F, Zerbi A. Long-term outcomes after pancreatoduodenectomy for ampullary cancer: The influence of the histological subtypes and comparison with the other periampullary neoplasms. Pancreatology 2021;21:950-6. [PMID: 33795194 DOI: 10.1016/j.pan.2021.03.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Jensen KK, Storkholm JH, Chen I, Burgdorf SK, Hansen CP. Long-term results after resection of primary duodenal adenocarcinoma: A retrospective cohort study. International Journal of Surgery 2022. [DOI: 10.1016/j.ijsu.2022.106599] [Reference Citation Analysis]
8 Doepker MP, Thompson ZJ, Centeno BA, Kim RD, Wong J, Hodul PJ. Clinicopathologic and survival analysis of resected ampullary adenocarcinoma. J Surg Oncol 2016;114:170-5. [PMID: 27158031 DOI: 10.1002/jso.24281] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
9 Feretis M, Wang T, Iype S, Duckworth A, Brais R, Basu B, Jamieson NV, Huguet E, Balakrishnan A, Jah A, Praseedom RK, Harper SJ, Liau SS. Development of a Prognostic Model That Predicts Survival After Pancreaticoduodenectomy for Ampullary Cancer. Pancreas 2017;46:1314-21. [PMID: 28902764 DOI: 10.1097/MPA.0000000000000929] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Nadeau K, Brule M. Gastrointestinal Malignancy Presenting with a Virchow's Node in a Patient with Rothmund-Thomson Syndrome. Case Rep Genet 2018;2018:7536832. [PMID: 30498607 DOI: 10.1155/2018/7536832] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Kimura J, Sui K, Tabuchi M, Murokawa T, Sakamoto S, Iwata J, Matsumoto M, Okabayashi T. First case report of neoadjuvant gemcitabine and S-1 for locally advanced unresectable duodenal adenocarcinoma. Surg Case Rep 2022;8:98. [PMID: 35585218 DOI: 10.1186/s40792-022-01453-2] [Reference Citation Analysis]
12 Maguire A, Sheahan K. Primary small bowel adenomas and adenocarcinomas-recent advances. Virchows Arch 2018;473:265-73. [PMID: 29998424 DOI: 10.1007/s00428-018-2400-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
13 Téoule P, Distler M, Niedergethmann M, Gaiser T, Rückert F, Grützmann R, Wilhelm TJ. Retrospective analysis of prognostic factors in patients with duodenal adenocarcinoma. Eur Surg 2016;48:228-34. [DOI: 10.1007/s10353-015-0374-0] [Reference Citation Analysis]
14 Meijer LL, Alberga AJ, de Bakker JK, van der Vliet HJ, Le Large TYS, van Grieken NCT, de Vries R, Daams F, Zonderhuis BM, Kazemier G. Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis. Ann Surg Oncol. 2018;25:2681-2692. [PMID: 29946997 DOI: 10.1245/s10434-018-6567-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
15 Chuang PJ, Wang HP, Lin YJ, Chen CC, Tien YW, Hsieh MS, Yang SH, Yen RF, Ko CL, Wu YW, Cheng MF. Preoperative 2-[18F]FDG PET-CT aids in the prognostic stratification for patients with primary ampullary carcinoma. Eur Radiol 2021. [PMID: 33864503 DOI: 10.1007/s00330-021-07923-9] [Reference Citation Analysis]
16 Herman JM, Pawlik TM, Merchant NB, Tamm EP, Vauthey J. Ampulla of Vater. In: Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR, editors. AJCC Cancer Staging Manual. Cham: Springer International Publishing; 2017. pp. 327-35. [DOI: 10.1007/978-3-319-40618-3_27] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Lancellotta V, Russo G, Lupattelli M, Iacco M, Perrucci E, Zucchetti C, Falcinelli L, Aristei C. Helical tomotherapy for duodenal adenocarcinoma in an elderly patient: A case report. World J Gastrointest Oncol 2017; 9(2): 94-97 [PMID: 28255431 DOI: 10.4251/wjgo.v9.i2.94] [Reference Citation Analysis]
18 Nassour I, Christie A, Choti MA, Mansour JC, Minter RM, Polanco PM, Augustine MM, Porembka MR, Xie X, Wang SC. Determining the Adequate Examined Lymph Node Count in Resected Ampullary Adenocarcinoma—A National Cohort Study. J Gastrointest Surg 2018;22:792-801. [DOI: 10.1007/s11605-018-3737-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Gao Y, Zhu Y, Huang X, Wang H, Yuan Z. Transduodenal ampullectomy provides a less invasive technique to cure early ampullary cancer. BMC Surg. 2016;16:36. [PMID: 27251044 DOI: 10.1186/s12893-016-0156-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]